Clinical spectrum and pathological features of multiple system atrophy

Movement Disorders

Volumn , Issue , 2005, Pages 541-570

  Colosimo, Carlo ^a   Geser, Felix ^b   Wenning, Gregor K ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649337826     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088382-0/50049-9     Document Type: Chapter

References (315)

1. Abbruzzese G., Marchese R., Trompetto C. Sensory and motor evoked potentials in multiple system alrophy: comparative study with Parkinson's disease. Mov Disord 1997, 12:315-321.
2. Abele M., Burk K., Schols L., Schwartz S., Besenthal I., Dichgans J., Zuhlke C., Riess O., Klockgether T. The aetiology of sporadic adult-onset ataxia. Brain 2002, 125:961-968.
3. Abele M., Schulz J.B., Burk K., Topka H., Dichgans J., Klockgether T. Evoked potentials in multiple system atrophy (MSA). Acta Neurol Scand 2000, 101:111-115.
4. Abele M., Schulz J.B., Burk K., Topka H., Dichgans J., Klockgether T. Nerve conduction studies in multiple system atrophy. Eur Neurol 2000, 43:221-223.
5. Abeliovich A., Schmitz Y., Farinas I., Lundberg D., Ho W.H., Castillo P.E., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
6. Adams R.D., van Bogaert L., van der Eecken H. Dégénérescences nigro-striées et cérébello-nigro-striees. Psychiatria et Neurologia 1961, 142:219-259.
7. Adams R.D., van Bogaert L., van der Eecken H. Striato-nigral degeneration. J Neuropath Exp Neurol 1964, 23:584-608.
8. Alam M., Smith G., Bleasdal-Barr K., Pavitt D.V., Mathias C.J. Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens 1995, 13:1664-1669.
9. Albanese A., Colosimo C., Bentivoglio A.R., Fenici R., Melillo G., Colosimo C., et al. Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry 1995, 59:144-151.
10. Ansorge O., Lees A.J., Brooks D.J., Daniel S.E. Multiple system atrophy presenting as progressive supranuclear palsy and viceversa: two unusual cases. Mov Disord 1997, 12(suppl.1):96.
11. Ansorge O., Lees A.J., Daniel S.E. Pathological overlap of Alzheimer's disease, Parkinson's disease and multiple system atrophy. Neuropathol Appl Neurobiol 1997, 23:179.
12. Arima K., Ueda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H., Kawai M. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol (Berl) 1998, 96:439-444.
13. Bandmann O., Wenning G.K., Quinn N.P., Harding A.E. Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 1995, 59:557.
14. Bandmann O., Sweeney M.G., Daniel S.E., Wenning G.K., Quinn N., Marsden C.D., Wood N.W. Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration. Neurology 1997, 49:1598-1604.
15. Bannister R., Ellison M., Morgan-Hughes J. Histological studies of skeletal and smooth muscles in autonomic failure. Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System 1999, 340-341. University Press, Oxford. C.J. Mathias, R. Bannister (Eds.).
16. Bannister R., Mathias C.J. Clinical features and evaluation of the primary chronic autonomic failure syndromes. Autonomic Failure A Textbook of Clinical Disorders of the Autonomic Nervous System 1999, 307-316. University Press, Oxford. C.J. Mathias, R. Bannister (Eds.).
17. Bannister R., Mathias C.J. Investigation of autonomic disorders. Autonomic failure. A Textbook of Clinical Disorders of the Autonomic Nervous System 1999, 169-195. University Press, Oxford. C.J. Mathias, R. Bannister (Eds.).
18. Bannister R., Oppenheimer D.R. Degenerative diseases of the nervous system associated with autonomic failure. Brain 1972, 95:457-474.
19. Baser S.M., Meer J., Polinsky R.J., Hallett M. Sudomotor function in autonomic failure. Neurology 1991, 41:1564-1566.
20. Beck R.O., Betts C.D., Fowler C.J. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 1994, 151:1336-1341.
21. Benarroch E.E., Smithson I.L., Low P.A., Parisi J.E. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol 1998, 43:156-163.
22. Ben-Shlomo Y., Wenning G.K., Tison F., Quinn N.P. Survival of patients with pathologically proven multiple system atrophy: a metaanalysis. Neurology 1997, 48:384-393.
23. Berciano J., Combarros O., Polo J.M., Pascual J., Oterino A. Who first described striatonigral degeneration?. Neurology 1998, 50(suppl 4):120.
24. Berciano J., Ferrer I. Glial and neuronal cytoplasmic inclusions in familial olivopontocerebellar atrophy. Ann Neurol 1996, 40:819-820.
25. Berciano J., Valldeoriola F., Ferrer I., Rumia J., Pascual J., Marin C., Rey M.J., Tolosa E. Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Mov Disord 2002, 17:812-816.
26. Bordet R., Benhadjali J., Libersa C., Desteè A. Octreotide in the managment of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration. Clin Neuropharmacol 1994, 17:380-383.
27. Bordet R., Benhadjali J., Desteè A., Belabbas A., Libersa C. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration. Clin Neuropharmacol 1995, 18:83-89.
28. Bösch S.M., Schocke M., Seppi K., Hollosi P., Poewe W., Wenning G.K. Abnormal striatal dopaminergic function in SCA2 revealed by beta-CIT and IBZM SPECT. Mov Disord 2002, 17(Suppl 5):311.
29. Bösch S.M., Wenning G.K., Ransmayr G., Poewe W. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002, 72:300-303.
30. Botez M.I., Botez-Marquard T., Elie R., Pedraza O.L., Goyette K., Lalonde R. Amantadine hydrochloride treatment in heredode generative ataxias: a double blind study. J Neurol Neurosurg Psychiatry 1996, 61:259-264.
31. Botez M.I., Young S.N. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredodegenrative ataxias. Can J Neurol Sci 2001, 28:134-140.
32. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence of progressive supranuclear plasy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997, 49:1284-1288.
33. Braak H., Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989, 15:13-26.
34. Braune S., Auer A., Schulte-Mönting J., Schwerbrock S., Lücking C.H. Cardiovascular parameters: sensitivity to detect autonomic dysfunction and influence of age and sex in normal subjects. Clinical Autonomic Research 1996, 6:3-15.
35. Braune S., Schulte-Monting J., Schwerbrock S., Lucking C.H. Retest variation of cardiovascular parameters in autonomic testing. J Auton Nerv Syst 1996, 60:103-107.
36. Braune S., Elam M., Baron R., Low P.A. Assessment of blood pressure regulation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999, 52:287-291.
37. Braune S., Reinhardt M., Schnitzer R., Riedel A., Lücking C.H. Cardiac uptake of (123I) MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999, 53:1020-1025.
38. Brenneis C., Seppi K., Schocke M.F., Müller J., Luginger E., Bösch S., Löscher W., Büchel C., Poewe W., Wenning G.K. Voxel-based morphometry detects cortical atrophy in the parkinson variant of multiple system atrophy. Mov Disord 2003, 18:1132-1138.
39. Brooks D.J., Luthert P., Gadian D., Marsden C.D. Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2-values and iron levels. J Neurol Neurosurg Psychiatry 1989, 52:108-111.
40. Brooks D.J., Ibanez V., Sawle G.V., et al. Differing patterns of striatal 18-F-Dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1990, 28:547-555.
41. Brooks D.J., Salmon E.P., Mathias C.J., et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 1990, 113:1539-1552.
42. Brooks D.J., Ibanez V., Sawle G.V., Playford E.D., Quinn N., Mathias C.J., Lees A.J., Marsden C.D., Bannister R., Frackowiak R.S. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11 C-raclopride and positron emission tomography. Ann Neurol 1992, 31:184-192.
43. Brown R.G., Pillon B., Uttner I., Payan C., Lacomblez L. Cognitive function in patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). Mov. Disord 2002, 17(Suppl 5):221. Members of the Neuropsychology Working Group and NNIPPS Consortium.
44. Brücke T., Wenger S., Asenbaum S. Dopamine D2 receptor imaging and measurement with SPECT. Adv Neurol 1993, 60:494-500.
45. Brücke T., Asenbaum S., Pirker W., Djamshidian S., Wenger S., Wober C., Muller C., Podreka I. Measurement of the dopaminergic degeneration in Parkinson's disease with [123] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 1997, 50:9-24.
46. Brücke T., Djamshidian S., Bencsits G., Pirker W., Asenbaum S., Podreka I. SPECT and PET imaging of the dopaminergic system in Parkinson's disease. J Neurol 2000, 247:2-7.
47. Burn D.J., Sawle G.V., Brooks D.J. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18 F-dopa PET data. J Neurol Neurosurg Psychiatry 1994, 57:278-284.
48. Burn D.J., Rinne J.O., Quinn N.P., Lees A.J., Marsden C.D., Brooks D.J. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome. A [11C]diprenorphine PET study. Brain 1995, 118:951-958.
49. Cairns N.J., Atkinson P.F., Hanger D.P., Anderton B.H., Daniel S.E., Lantos P.L. Tau protein in the glial cytoplasmatic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett 1997, 230:49-52.
50. Cairns N.J., Atkinson P.F., Kovacs T., Lees A.J., Daniel S.E., Lantos P.L. Apolipoprotein E ?4 allele frequency in patients with multiple system atrophy. Neurosci Lett 1997, 221(2-3):161-164.
51. Caplan L.R. Clinical features of sporadic (Dejerine-Thomas) olivopontocerebellar atrophy. Adv Neurol 1984, 41:217-224.
52. Chandiramani V.A., Palace J., Fowler C.J. How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol 1997, 80:100-104.
53. Chin S.S., Goldman J.E. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996, 55:499-508.
54. Chio A., Magnani C., Schiffer D. Prevalence of Parkinson's disease in northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 1998, 13:400-405.
55. Churchyard A., Donnan G.A., Hughes A., Howells D.W., Woodhouse D., Wong J.Y., Kalnins R.M., Mendelsohn F.A., Paxinos G. Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors. Ann Neurol 1993, 34:219-226.
56. Clarke C.E., Lowry M. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. Eur J Neurol 2000, 7:661-665.
57. Cohen J., Low P., Fealey R., Sheps S., Jiang N.S. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol 1987, 22:692-699.
58. Colosimo C. Pisa syndrome in a patient with multiple system atrophy. Mov Disord 1998, 13:607-609.
59. Colosimo C., Albanese A., Hughes A.J., de Bruin V.M., Lees A.J. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995, 52(3):294-298.
60. Colosimo C., Inghilleri M., Chaudhuri K.R. Parkinson's disease misdiagnosed as multiple system atrophy by sphincter electromyography. J Neurol 2000, 247:559-561.
61. Colosimo C., Merello M., Pontieri F.E. Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study. J Neurol 1996, 243:422-425.
62. Colosimo C., Pezzella F.R. The symptomatic treatment of multiple system atrophy. Eur J Neurol 2002, 9:195-199.
63. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Neurol Sci 1996, 144:218-219.
64. Cortes R., Camps M., Gueye B., Probst A., Palacios J.M. Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology. Brain Res 1989, 483(1):30-38.
65. Daniel S.E. The neuropathology and neurochemistry of multiple system atrophy. Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System 1999, 321-328. Oxford University Press, Oxford. C.J. Mathias, R. Bannister (Eds.).
66. Daniel S.E., Geddes J.F., Revesz T. Glial cytoplasmic inclusions are not exclusive to multiple system atrophy. J Neurol Neurosurg Psychiatry 1995, 58:262.
67. Davie C.A., Wenning G.K., Barker G.J., Tofts P.S., Kendall B.E., Quinn N., et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995, 37:204-210.
68. Dejerine J., Thomas A.A. L'atrophie olivo-ponto-cérébelleuse. Nouvelle Iconographie de le Salpétrière 1900, 13:330-370.
69. De Volder A.G., Francart J., Laterre C., Dooms G., Bol A., Michel C., et al. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. Ann Neurol 1989, 26:239-247.
70. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114:1953-1975.
71. Dickson D.W., Lin W., Liu W.K., Yen S.H. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 1999, 9:721-732.
72. Djaldetti R., Mosberg-Galili R., Sroka H., Merims D., Melamed E. Camptocornia (bent spine) in patients with Parkinson's disease-characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 1999, 14:443-447.
73. Drayer B.P., Olanow W., Burger P., Johnson G.A., Herfkens R., Riederer S. Parkinson Plus Syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986, 159:493-498.
74. Eardley I., Quinn N.P., Fowler C.J., Kirby R.S., Parkhouse H.F., Marsden C.D., et al. The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. British Journal of Urology 1989, 64:360-362.
75. Eichhorn T.E., Oertel W.H. Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 2001, 16:1176-1177.
76. Eidelberg D., Takikawa S., Moeller J.R., Dhawan V., Redington K., Chaly T., et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 1993, 33:518-527.
77. El-Agnaf O.M., Curran M.D., Wallace A., Middleton D., Murgatroyd C., Curtis A., Perry R., Jaros E. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. Neuroreport 1998, 9:3925-3927.
78. Engelender S., Karninsky Z., Guo X., Sharp A.H., Amaravi R.K., Kleiderlein J.J., Margolis R.L., Troncoso J.C., Lanahan A.A., Worley P.F., Dawson V.L., Dawson T.M., Ross C.A. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 1999, 22:110-114.
79. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
80. Fearnley J.M., Lees A.J. Striatonigral degeneration: A clinicopathological study. Brain 1990, 113:1823-1842.
81. Federico F., Simone I.L., Lucivero V., Mezzapesa D.M., de Mari M., Lamberti P., et al. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes. Ital J Neurol Sci 1999, 20(4):223-229.
82. Fleischhacker H. Afamiliäre chronisch progressive Erkrankung des mittleren Lebensalters vom Pseudosklerosetyp. Z Gesamte Neurol Psychiatrie 1924, 91:1-22.
83. Freeman R., Landsberg L., Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threodihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 1999, 53:2151-2157.
84. Flugel K.A., Mosler T.A., Wild R.H. Bulbar paralytic symptoms including acute vocal cord paralysis in Shy-Drager syndrome. Nervenarzt 1984, 55(6):293-298.
85. Fujita T., Doi M., Ogata T., Kanazawa I., Mizusawa H. Cerebral cortical pathology of sporadic olivopontocerebellar atrophy. J Neurol Sci 1993, 116(1):41-46.
86. Futamura N., Matsumura R., Fujimoto Y., Horikawa H., Suzumura A., Takayanagi T. CAG repeat expansions in patients with sporadic cerebellar ataxia. Acta Neurol Scand 1998, 98:55-59.
87. Gai W.P., Power J.H., Blumbergs P.C., Blessing W.W. Multiple-system atrophy: a new alpha-synuclein disease?. Lancet 1998, 352(9127):547-548.
88. Galassi G., Nemni R., Baraldi A., Gibertoni M., Colombo A. Peripheral neuropathy in multiple system atrophy with autonomic failure. Neurology 1982, 32:1116-1121.
89. Garratt H., Wenning G.K., Barnes C., Howard R., Quinn N.P. Speech dysfunction and levodopa response in multiple system atrophy. New Trends in Clinical Neuropharmacology 1994, 207-208.
90. Ghorayeb I., Yekhlef F., Chrysostome V., Balestre E., Bioulac B., Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002, 72:798-800.
91. Giladi N., Simon E.S., Korczyn A.D., Groozman G.B., Orlov Y., Shabtai H., Drory V.E. Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease. Muscle Nerve 2000, 23:731-734.
92. Gilman S., Koeppe R.A., Junck L., Kluin K.J., Lohman M., St.Laurent R.T. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1994, 36:166-175.
93. Gilman S., Sima A.A., Junck I., Kluin K.J., Koeppe R.A., Lohman M.E., Little R. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 1996, 39(2):241-255.
94. Gilman S., Low P., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C., Kaufmann H., Klockgether T., Lang A., Lantos P., Litvan I., Mathias C., Oliver E., Robertson D., Schatz I., Wenning G. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 1998, 8:359-362.
95. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999, 163:94-98.
96. Gilman S., Little R., Johanns J., Heumann M., Kluin K.J., Junck L., Koeppe R.A. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology 2000, 55:527-532.
97. Goedert M., Spillantini M.G. Lewy body diseases and multiple system atrophy as alpha-synucleinopathies. Mol Psychiatry 1998, 3:462-465.
98. Gonzalez-Quevedo A., Garcia J.C., Fernandez R., Fernandez Cartaya L. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. Bol Estud Med Biol 1993, 41:13-19.
99. Goto S., Hirano A., Matsumoto S. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann Neurol 1989, 26:766-770.
100. Goto S., Hirano A., Rojas-Corona R.R. Calcineurin immunoreactivity in striatonigral degeneration. Acta Neuropathol (Berl) 1989, 78:65-71.
101. Goto S., Hirano A., Rojas-Corona R.R. Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders. Acta Neuropathol (Berl) 1989, 78:543-550.
102. Goto S., Hirano A., Matsumoto S. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Neurology 1990, 40:1051-1056.
103. Goto S., Matsumoto S., Ushio Y., Hirano A. Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration. Neurology 1996, 47:1032-1036.
104. Gouider-Khouja N., Vidailhet M., Bonnet A.M., Pichon J., Agid Y. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov Disord 1995, 10:288-294.
105. Graham J.G., Oppenheimer D.R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969, 32:28-34.
106. Gu M., Gash M.T., Cooper J.M., Wenning G.K., Daniel S.E., Quinn N.P., Marsden C.D., Schapira A.H. Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 1997, 12:418-422.
107. Hayashi M., Isozaki E., Oda M., Tanabe H., Kimura J. Loss of large myelinated nerve fibers of the recurrent laryngeal nerve in patients with multiple system atrophy and vocal cord palsy. J Neurol Neurosurg Psychiatry 1997, 62:234-238.
108. Holmberg B., Johnels B., Ingvarsson P., Eriksson B., Rosengren L. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of parkinsonian syndromes. Park Relat Disord 2001, 8:23-31.
109. Holmberg B., Rosengren L., Karlsson J.E., Johnels B. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov Disord 1998, 13:70-77.
110. Horoupian D.S., Dickson D.W. Striatonigral degeneration, olivopontocerebellar atrophy and "atypical" Pick disease. Acta Neuropathol (Berl) 1991, 81(3):287-295.
111. Hu M.T.M., Simmons A., Glover A., et al. Proton magnetic resonance spectroscopy of the putamen in Parkinson's disease and multiple system atrophy. Mov Disord 1998, 13:182.
112. Huang Y.P., Plaitakis A. Morphological changes of olivopontocerebellar atrophy in computed tomography and comments on its pathogenesis. Adv Neurol 1984, 41:39-85.
113. Hughes A.J., Colosimo C., Kleedorfer B., Daniel S.E., Lees A.J. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992, 55:1009-1013.
114. Hughes R.G., Gibbin K.P., Lowe J. Vocal fold abductor paralysis as a solitary and fatal manifestation of multiple system atrophy. J Laryngeol Otol 1998, 112(2):177-178.
115. Hussain I.F., Brady C.M., Swinn M.J., Mathias C.J., Fowler C.J. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001, 71:371-374.
116. Iranzo A., Santamaria J., Tolosa E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet 2000, 356:1329-1330.
117. Ito H., Kusaka H., Matsumoto S., Imai T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 1996, 47:1291-1299.
118. Iwahashi K., Miyatake R., Tsuneoka Y., Matsuo Y., Ichikawa Y., Hosokawa K., Sato K., Hayabara T. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 1995, 58:263-264.
119. Jankovic J., Gilden J.L., Hiner B.C., Kaufmann H., Brown D.C., Coghlan C.H., Rubin M., Fouad-Tarazi F.M. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993, 95:38-48.
120. Jost W.H., Schimrigk K. Urinary incontinence in patients with Parkinson syndrome. Wien Klin Wochenschr 1996, 108:296-302.
121. Kato S., Oda M., Hayashi H., Shimizu T., Hayashi M., Kawata A., Tanabe H. Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis. J Neurol Sci 1995, 132:216-221.
122. Kaufmann H., Oribe E., Miller M., Knott P., Wiltshire-Clement M., Yahr M.D. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology 1992, 42:590-593.
123. Kew J., Gross M., Chapman P. Shy-Drager syndrome presenting as isolated paralysis of vocal cord abductors. BMJ 1990, 300:1441.
124. Kihara M., Suganoya J., Takahashi A. The assessment of sudomotor dysfunction in multiple system atrophy. Clin Auton Res 1991, 1:297-302.
125. Kimber J.R., Watson L., Mathias C.J. Distinction of idiopathic Parkinson's disease from multiple system atrophy by stimulation of growth-hormone release with clonidine. Lancet 1997, 349:1877-1881.
126. Kirby R., Fowler C.J., Gosling J., Bannister R. Urethro-vesical dysfunction in progressive autonomic failure with multiple system atrophy. J Neurol Neurosurg Psychiatry 1986, 49:554-562.
127. Kiyosawa K., Mokuno K., Murakami N., Yasuda T., Kume A., Hashizume Y., Takahashi A., Kato K. Cerebrospinal fluid 28-kDa calbindin-D as a possible marker for Purkinje cell damage. J Neurol Sci 1993, 118:29-33.
128. Klein C., Wenning G.K., Quinn N.P. Pseudotransitory ischemic attacks as the initial symptom of multiple system atrophy. Nervenarzt 1995, 66:133-135.
129. Klein C., Brown R., Wenning G., Quinn N. The "cold hand sign" in multiple system atrophy. Mov Disord 1997, 12:514-518.
130. Klockgether T., Faiss J., Poremba M., Dichgans J. The development of infratentorial atrophy in patients with idiopathic cerebellar ataxia of late onset: a CT study. J Neurol 1990, 237:420-423.
131. Klockgether T., Schroth G., Diener H.C., Dichgans J. Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J Neurol Neurosurg Psychiatry 1990, 53:297-305.
132. Kluin K.J., Gilman S., Lohmann M., Junck L. Characteristics of the dysarthria of multiple system atrophy. Arch Neurol 1996, 53:545-548.
133. Kodama Y., Ieda T., Hirayama M., Koike Y., Ito H., Sobue G. Auditory brainstem responses in patients with autonomic failure with Parkinson's disease and multiple system atrophy. J Auton Nerv Syst 1999, 77:184-189.
134. Kofler M., Müller J., Wenning G.K., Reggiani L., Hollosi P., Bösch S., et al. The auditory startle reaction in parkinsonian disorders. Mov Disord 2001, 16:62-71.
135. Konagaya M., Konagaya Y., Honda H., Iida M. A clinico-MRI study of extrapy ramidal symptoms in multiple system atrophy-linear hyperintensity in the outer margin of the putamen. No To Shinkei 1993, 45:509-513.
136. Konagaya M., Konagaya Y., Iida M. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. J Neurol Neurosurg Psychiatry 1994, 57:1528-1531.
137. Konagaya M., Sakai M., Matsuoka Y., Goto Y., Yoshida M., Hashizume Y. Patho-MR imaging study in the putaminal margin in multiple system atrophy. No To Shinkei 1998, 50:383-385.
138. Konagaya M., Sakai M., Matsuoka Y., Konagaya Y., Hashizume Y. Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol (Berl) 1999, 97:423-428.
139. Konagaya M., Konagaya Y., Sakai M., Matsuoka Y., Hashizume Y. Progressive cerebral atrophy in multiple system atrophy. J Neurol Sci 2002, 195:123-127.
140. Konno H., Yamamoto T., Iwasaki Y., Iizuka H. Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci 1986, 73:193-204.
141. Kraft E., Trenkwalder C., Auer D.P. T2-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002, 59:1265-1267.
142. Kraft E., Schwarz J., Trenkwalder C., Vogl T., Pfluger T., Oertel W.H. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resomance imaging sequences: a specific marker of multiple system atrophy?. Arch Neurol 1999, 56:225-228.
143. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala 30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998, 18:106-108.
144. Kruger R., Vieira-Saecker A.M., Kuhn W., Berg D., Muller T., Kuhnl N., Fuchs G.A., Storch A., Hungs M., Woitalla D., Przuntek H., Epplen J.T., Schols L., Riess O. Increased susceptibility to sporadic Parkinson's disease by acertain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol 1999, 45:611-617.
145. Kume A., Takahashi A., Hashizume Y. Neuronal cell loss of the striatonigral system in multiple system atrophy. J Neurol Sci 1993, 117:33-40.
146. Lambie C.G., Latham O., MacDonald G.L. Olivo-pontocerebellar atrophy (Marie's ataxia). Medical Journal of Australia 1947, 2:626-632.
147. Lang A.E., Curran T., Provias J., Bergeron C. Striatonigral degeneration: iron deposition in putamen correlated with the slit-like void signal of magnetic resonance imaging. Can J Neurol Sci 1994, 21:311-318.
148. Langston W. Orthostatic hypotension: report of a case. Ann Int Med 1936, 10:688-695.
149. Lantos P.L. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 1998, 57:1099-1111.
150. Lees A.J., Bannister R. The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy Drager syndrome). J Neurol Neurosurg Psychiatry 1981, 44:347-351.
151. Lees A.J. The treatment of the motor disorders of multiple system atrophy. Autonomic Failure 1999, 357-363. University Press, Oxford. C.J. Mathias, R. Bannister (Eds.).
152. Leggo J., Dalton A., Morrison P.J., Dudge A., Connarty M., Kotze M.J., et al. Analysis of spinocerebellar ataxia types 1, 2, 3, and 6, dentatorubral-pallidoluysian atrophy, and Friedreich's ataxia genes in spinocerebellar ataxia patients in the UK. J Med Genet 1997, 34:982-985.
153. Libelius R., Johannson F. Quantitative electromy ography of the external anal sphincter in Parkinson's disease and multiple system atrophy. Muscle & Nerve 2000, 23:1250-1256.
154. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., Goetz C.G., Golbe L.I., Grafman J., Growdon J.H., Hallett M., Jankovic J., Quinn N.P., Tolosa E., Zee D.S. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
155. Litvan I., Goetz C.G., Jankovic J., Wenning G.K., Booth V., Bartko J.J., McKee A., Jellinger K., Lai E.C., Brandel J.P., Verny M., Chaudhuri K.R., Pearce R.K., Agid Y. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997, 54:937-944.
156. Litvan I., Booth V., Wenning G.K., Bartko J.J., Goetz C.G., McKee A., Jankovic J., Jellinger K., Lai E.C., Brandel J.P., Verny M., Chaudhuri K.R., Pearce R.K., Agid Y. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm 1998, 105:217-227.
157. Low P.A., Gilden J.L., Freeman R., Sheng K.N., McElligott M.A. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study, Midodrine Study Group. JAMA 1997, 277:1046-1051.
158. Magnifico F., Pierangell G., Barletta G., et al. The cardiovascular effects of metoclopramide in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001, 11:163-168.
159. Martignoni E., Blandini F., Petraglia F., Pacchetti C., Bono G., Nappi G. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. J Neural Transm [Park Dis Dement Sect] 1992, 4(3):191-205.
160. Martinelli P., Coccagna G. Etude electromyographique du sphincter strie de l'anus dans trois cas de syndrome de Shy-Drager. Joulouse: Premieres Journess Languedociennes d'Electromyographie 1978, 321-326. L. Arbus, J. Cadilhac (Eds.).
161. Mathias C.J., Fosbraey P., da Costa D.F., Thornley A., Bannister R. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. BMJ (Clin Res Ed) 1986, 293:353-354.
162. Mathias C.J., Kimber J.R. Postural hypotension: causes, clinical features, investigation, and management. Annu Rev Med 1999, 50:317-336.
163. Mathias C.J., Senard J.M., Braune S., Watson L., Aragishi A., Keeling J.E., et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multinational, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001, 11:235-242.
164. Matthews M.R. Autonomic ganglia and preganglionic neurones in autonomic failure. Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System 1999, 329-339. University Press, Oxford. C.J. Mathias, R. Bannister (Eds.).
165. Meco G., Gasparini M., Doricchi F. Attentional functions in multiple system atrophy and Parkinson's disease. J Neurol Neurosurg Psychiatry 1996, 60:393-398.
166. Merlo I.M., Occhini A., Pacchetti C., Alfonsi E. Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology 2002, 58:649-652.
167. Montagna P., Martinelli P., Rizzuto N., Salviati A., Rasi F., Lugaresi E. Amyotrophy in Shy-Drager syndrome. Acta Neurol Belg 1983, 83:142-157.
168. Morris H.R., Vaughan J.R., Datta S.R., Bandopadhyay R., Rohan De Silva H.A., Schrag A., et al. Multiple system atrophy/progressive supranuclear palsy: alpha-synuclein, synphilin, tau, and APOE. Neurology 2000, 55:1918-1920.
169. Moseley M.L., Benzow K.A., Schut L.J., Bird T.D., Gomez C.M., Barkhaus P.E., Blindauer K.A., Labuda M., Pandolfo M., Koob M.D., Ranum L.P. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia familie. Neurology 1998, 51:1666-1671.
170. Muller J., Wenning G.K., Verny M., McKee A., Chaudhuri K.R., Jellinger K., Poewe W., Litvan I. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 2001, 58:259-264.
171. Müller J., Wenning G.K., Jellinger K., McKee A., Poewe W., Litvan I. Progression of Hoehn and Yahr stages in parkinsonian disorders: a clinicopathologic study. Neurology 2000, 55:888-891.
172. Nakamura S., Ohnishi K., Nishimura M., Suenaga T., Akiguchi I., Kimura J., Kimura T. Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy. Neurology 1996, 46:1693-1696.
173. Nee L.E., Gomez M.R., Dambrosia J., Bale S., Eldridge R., Polinsky R.J. Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation I 1991, 1:9-13.
174. Neumann M.A. Pontocerebellar atrophy combined with vestibular-reticular degeneration. J Neuropathol Exp Neurol 1977, 36:321-337.
175. Nicholl D.J., Bennett P., Hiller L., Bonifati V., Vanacore N., Fabbrini G., et al. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 1999, 53:1415-1421.
176. Nutt J.G., Mrox E.A., Leeman S.E., Williams A.C., Engel W.K., Chase T.N. Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction. Neurology 1980, 30:1280-1285.
177. O'Brien C., Sung J.H., McGeachie R.E., Lee M.C. Striatonigral degeneration: clinical, MR1, and pathologic correlation. Neurology 1990, 40:710-711.
178. Oertel W.H., Wachter T., Quinn N., Ulm G., Brandstädter D. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type (MSA-P). Mov Disord 2003, 18:430-432.
179. Olanow C.W. Magnetic resonance imaging in parkinsonism. Neurol Clin 1992, 10:405-420.
180. Oppenheimer D. Diseases of the basal ganglia, cerebellum and motor neurons. Greenfield's Neuropathology 1984, 699-747. Wiley, New York. J.H. Adams, J.A.N. Corsellis, L.W. Duchen (Eds.).
181. Oppenheimer D.R. Lateral horn cells in progressive autonomic failure. J Neurol Sci 1980, 46:393-404.
182. Orimo S., Ozawa E., Nakade S., Sugimoto T., Mizusawa H. (123)I-metaiod obenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999, 67:189-194.
183. Orozco G., Estrada R., Perry T.L., Arana J., Fernandez R., Gonzalez-Quevedo A., Galarraga J., Hansen S. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J Neurol Sci 1989, 93:37-50.
184. Osaki Y., Wenning G.K., Daniel S.E., Hughes A., Lees A.J., Mathias C.J., Quinn N. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?. Neurology 2002, 59:1486-1491.
185. Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J., Wolozin B. alpha-synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 1999, 19:5782-5791.
186. Ozawa T., Takamo H., Onodera O., Kobayashi H., Ikeuchi T., Koidel R. No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 1999, 270:110-112.
187. Palace J., Chandiramani V.A., Fowler C.J. Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle & Nerve 1997, 20:1396-1403.
188. Papp M.I., Kahn J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989, 94:79-100.
189. Papp M.I., Lantos P.L. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992, 107:172-182.
190. Papp M.I., Lantos P.L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994, 117:235-243.
191. Parati E.A., Fetoni V., Geminiani G.C., Soliveri P., Giovannini P., Testa D., Genitrini S., Caraceni T., Girotti F. Response to L-dopa in multiple system atrophy. Clin Neuropharmacol 1993, 16:139-144.
192. Pastakia B., Polinsky R., Di Chiro G., Simmon J.T., Brown R., Wener L. Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology 1986, 159:499-502.
193. Perani D., Bressi S., Testa D., Grassi F., Cortelli P., Genitrini S., et al. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F18 positron emission tomography study. Arch Neurol 1995, 52:179-185.
194. Perera R., Isola L., Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonornic failure. Clin Auton Res 1995, 5:211-213.
195. Pillon B., Gouider-Khouja N., Deweer B., Vidailhet M., Malapani C., Dubois B., et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995, 58:174-179.
196. Plaitakis A., Flessas P., Natsiou A.B., Shashidharan P. Glutamate dehydrogenase deficiency in cerebellar degenerations: clinical, biochemical and molecular genetic aspects. Can J Neurol Sci 1993, 20(Suppl 3):109-116.
197. Plazzi G., Corsini R., Provini F. REM sleep behavior disorders in multiple system atrophy. Neurology 1997, 48:1094-1097.
198. Polinsky R.J., Brown R.T., Lee G.K., Timmers K., Culman J., Foldes O., Kopin I.J., Recant L. Beta-endorphin, ACTH, and cate-cholamine responses in chronic autonomic failure. Ann Neurol 1987, 21:573-577.
199. Polinsky R.J., Kopin I.J., Ebert M.H., Weise V. Pharmacologic distinction of different orthostatic hypotension syndrome. Neurology 1981, 31:1-7.
200. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
201. Pramstaller P., Wenning G.K., Smith S.J.M., Beck R.O., Quinn N.P., Fowler C.J. Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J. Neurol. Neurosurg Psychiatry 1995, 58:618-621.
202. Prasher D., Bannister R. Brain stem auditory evoked potentials in patients with multiple system atrophy with progressive autonomic failure (Shy-Drager syndrome). J Neurol Neurosurg Psychiatry 1986, 49:278-289.
203. Price R.H., Albin R.L., Sakurai S.Y., Polinsky R.J., Penney J.B., Young A.B. Cerebellar excitatory and inhibitory amino acid receptors in multiple system atrophy. Neurology 1993, 43:1323-1328.
204. Quik M., Spokes E.G., Mackay A.V., Bannister R. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease. J Neurol Sci 1979, 43:429-437.
205. Quinn N. Disproportionate antecollis in multiple system atrophy. Lancet 1989, 1:844.
206. Quinn N. Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry 1989, 52(suppl):78-89.
207. Quinn N. Multiple system atrophy. Mov Disord 3 1994, 262-281. Butterworth-Heinemann, London. C.D. Marsden, S. Fahn (Eds.).
208. Quinn N.P., Wenning G., Marsden C.D. The Shy-Drager syndrome. What did Shy and Drager really describe?. Arch Neurol 1995, 52:656-657.
209. Raimbach S.J., Cortelli P., Kooner J.S., Bannister R., Bloon S.R., Mathias C.J. Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes. Clin Sci (Lond) 1989, 77:623-628.
210. Rajput A.H., Rozdilsky B., Rajput A., Ang L. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol 1990, 13:553-558.
211. Ranum L.P., Lundgren J.K., Schut L.J., Ahrens M.J., Perlman S., Aita J., et al. Spinocerebellar ataxia type 1 and Machado-Joseph-disease, incidence of CAG expansions among adult-onset at axia patients from 311 families with dominant, recessive, or sporadic ataxia. Am J Hum Genet 1995, 57:603-608.
212. Ravits J., Hallett M., Nilsson J., Polinsky R., Dambrosia J. Electrophysiological tests of autonomic function in patients with idiopathic autonomic failure syndromes. Muscle & Nerve 1996, 19:758-763.
213. Riley D.E., Chelimsky T.C. Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 2003, 74:56-60.
214. Rivest J., Quinn N., Marsden C.D. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990, 40:1571-1578.
215. Robbins T.W., James M., Lange K.W., Owen A.M., Quinn N.P., Marsden C.D. Cognitive performance in multiple system atrophy. Brain 1992, 115:271-291.
216. Rossi P., Colosimo C., Moro E., Tonali P., Albanese A. Acute challenge with apomorphine and levodopa in parkinsonism. Eur Neurol 2000, 43:95-101.
217. Sakakibara R., Hattori T., Uchiyama T., Kita K., Asahina M., Suzuki A., Yamanishi T. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation. J Neurol Neurosurg Psychiatry 2000, 68:65-69.
218. Sakakibara R., Hattori T., Uchiyama T., Suenaga T., Takahashi H., Yamanishi T., Egoshi K., Sekita N. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 2000, 79:191-195.
219. Salazar G., Valls-Sole J., Marti M.J., Chang H., Tolosa E.S. Postural and action myoclonus in patients with parkinsonian type of multiple system atrophy. Mov Disord 2000, 15:77-83.
220. Sandroni P., Ahlskog J.E., Fealy R.D., Low P.A. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res 1991, 1:147-155.
221. Santens P., Crevits L., Vander Linden C. Raynaud's phenomenon in a case of multiple system atrophy. Movement Disorders 1996, 11:586-588.
222. Savoiardo M., Strada L., Girotti F. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990, 174:693-696.
223. Schelosky L., Hierholzer J., Wissel L., Cordes M., Poewe W. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT. Mov Disord 1993, 8(4):453-458.
224. Scherer H.J. Beiträge zur pathologischen Anatomie des Kleinhirns. III. Mitteilung, Genuine Kleinhirnatrophien. Z. Gesamte Neurol Psychiatrie 1993, 145:335-405.
225. Scherer H.J. Extrapyramidale Störungen bei der olivopontocerebellären Atrophie. Z Gesamte Neurol Psychiatrie 1993, 145:406-419.
226. Scherfler C., Puschban Z., Ghorayeb I., Goebel G.P., Tison F., Jellinger K., et al. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience 2000, 99:43-54.
227. Schocke M., Seppi K., Esterhammer R., Kremser C., Jaschke W., Poewe W., et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002, 58:575-580.
228. Schöls L., Szymanski S., Peters S., Przuntek H., Epplen J.T., Hardt C., et al. Genetic background of apparently idiopathic sporadic cerebellar ataxia. Hum Genet 2000, 107:132-137.
229. Schrag A., Kingsley D., Phatouros C., Mathias C.J., Lees A.J., Daniel S.E., et al. Clinical use fulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998, 65:65-71.
230. Schrag A., Ben-Shlomo Y., Quinn N.P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999, 354:1771-1775.
231. Schrag A., Good C.D., Miszkiel K., Morris H.R., Mathias C.J., Lees A.J., et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000, 54:697-702.
232. Schulz J.B., Klockgether T., Petersen D., Jauch M., Muller-Schauenburg W., Spieker S., et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994, 57:1047-1056.
233. Schulz J.B., Skalej M., Wedekind D., Luft A.R., Abele M., Voigt K., et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999, 45:65-74.
234. Schwarz J., Tatsch K., Arnold G., Gasser T., Trenkwalder C., Kirsch C.M., et al. 1231-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology 1992, 42:556-561.
235. Schwarz J., Tatsch K., Arnold G., Ott M., Trenkwalder C., Kirsch C.M., Oertel W.H. 123l-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology 1993, 43:17-20.
236. Schwarz J., Weis S., Kraft E. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996, 60:98-101.
237. Schwarz J., Kornhuber M., Bischoff C., Straube A. Electromyography of the external anal sphincter in patients with Parkinson's disease and multiple system atrophy: frequency of abnormal spontaneous activity and polyphasic motor unit potentials. Muscle & Nerve 1997, 20(9):1167-1172.
238. Seppi K., Schocke M.F.H., Esterhammer R., Kremser C., Brenneis C., Mueller J., Boesch S., Jaschke W., Poewe W., Wenning G.K. DWI discriminates PSP from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003, 60:922-927.
239. Shy G.M., Drager G.A. A neurological syndrome associated with orthostatic hypotension. A clinicopathological study. Arch Neurol 1960, 2:511-527.
240. Silber M.H., Levine S. Stridor and death in multiple system atrophy. Mov Disord 2000, 15(4):699-704.
241. Silveira I., Lopes-Cendes I., Kish S., Maciel P., Gaspar C., Coutinho P., et al. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology 1996, 46:214-218.
242. Sima A.A.F., Caplan M., D'Amato C.J., Pevzner M., Furlong J.W. Fulminant multiple system atrophy in a young adult presenting as motor neuron disease. Neurology 1993, 43:2031-2035.
243. Sobue G., Terao S., Kachi T., Ken E., Hashizume Y., Mitsuma T., et al. Somatic motor efferents in multiple system atrophy with autonomic failure: a clinico-pathological study. J Neurol Sci 1992, 112:113-125.
244. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998, 251:205-208.
245. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
246. Spokes E.G., Bannister R., Oppenheimer D.R. Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J Neurol Sci 1979, 43:59-82.
247. Staal A., Meerwaldt J.D., van Dongen K.K., Mulder P.G.H., Busch H.F.M. Non-familial degenerative disease and atrophy of brain-stem and cerebellum. Clinical and CT data in 47 patients. J Neurol Sci 1990, 95:259-269.
248. zur Kenntnis des extrapyramidalen motorischen Systems und Mitteilung eines Falles von sog "Atrophie olivopontocérébelieus. Z Gesamte Neurol Psychiatrie 1918, 39:1-55.
249. Stern M.B., Braffman B.H., Skolnick B.E., Hurtig H.I., Grossman R.I. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989, 39:1524-1526.
250. Stocchi F., Badiali D., Vacca L., D'Alba L., Bracci F., Ruggieri S., Torti M., Berardelli A., Corazziari E. Anorectal function in multiple system atrophy and Parkinson's disease. Mov Disord 2000, 15:71-76.
251. Suemaru S., Suemaru K., Kawai K., Miyata S., Nobukuni K., Ihara Y., Namba R., Urakami K., Hashimoto K. Cerebrospinal fluid corticotrophin-releasing hormone in neurodegenerative diseases: reduction in spinocerebellar degeneration. Life Sci 1995, 57:2231-2235.
252. Sung J.H., Mastri A.R., Segal E. Pathology of Shy-Drager syndrome. J Neuropáthol Exp Neurol 1979, 38:353-368.
253. Takanashi M., Ohta S., Matsuoka S., Mori H., Mizuno Y. Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case. Acta Neuropathol (Berl) 2002, 103(1):82-87.
254. Takatsu H., Nagashima K., Murase M., Fujiwara H., Nishida H., Matsuo H. Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. JAMA 2000, 284(1):44-45.
255. Takei Y., Mirra S. Striatonigral degeneration: a form of multiple system atrophy with clinical parkinsonism. Progress in Neuropathology 1973, Vol. 2:217-251. Grune & Stratton, New York. H.M. Zimmermann (Ed.).
256. Taki J., Nakajima K., Hwang E.H., Matsmari I., Komai K., Yoshita M. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000, 27:566-573.
257. Terao S., Sobue G., Hashizume Y., Mitsuma T., Takahashi A. Disease-specific patterns of neuronal loss in the spinal ventral horn in amy otrophic lateral sclerosis, multiple system atrophy and X-linked recessive bulbospinal neuronopathy, with special reference to the loss of small neurons in the intermediate zone. J Neurol 1994, 241:196-203.
258. Testa D., Filippini G., Farinotti M., Palazzini E., Caraceni T. Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J Neurol 1996, 243:401-404.
259. Thobois S., Broussolle E., Toureille L., Vial C. Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy. Mov Disord 2001, 16:764-765.
260. Tison F., Wenning G.K., Daniel S.E., Quinn N. The pathophysiology of parkinsonism in multiple system atrophy. Eur J Neurol 1995, 2:435-444.
261. Tison F., Wenning G.K., Quinn N.P., Smith S.J. REM sleep behaviour disorder as the presenting symptom of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995, 58:379-380.
262. Tison F., Arne P., Sourgen C., Chrysostome V., Yeklef F. The value of extemal anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov Disord 2000, 15:1148-1157.
263. Tison F., Yekhlef F., Chrysostome V., Sourgen C. Prevalence of multiple system atrophy. Lancet 2000, 355:495-496.
264. Tohgi H., Tabuchi M., Tomonaga M., Izumiyama N. Selective loss of small myelinated and unmyelinated fibers in Shy-Drager syndrome. Acta Neuropathologica (Berlin) 1982, 57:282-286.
265. Tranchant C., Guiraud-Chaumeil C., Echaniz-Laguna A., Warter J.M. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?. J Neurol 2000, 247(11):853-856.
266. Trojanowski J.Q. Tauists, baptists, syners, apostates, and new data. Ann Neurol 2002, 52(3):263-265.
267. Tsuchiya K., Ozawa E., Haga C., Watabiki S., Ikeda M., Sano M., Ooe K., Taki K., Ikeda K. Constant involvement of the Betz cells and pyramidal tract in multiple system atrophy: a clinicopathological study of seven autopsy cases. Acta Neuropathol (Berl) 2000, 99(6):628-636.
268. Tsuchiya K., Watabiki S., Sano M., Iobe H., Shiotsu H., Taki K., Hashimoto K. Distribution of cerebellar cortical lesions in multiple system atrophy: atopographic neuropathological study of three autopsy cases in Japan. J Neurol Sci 1998, 155(1):80-85.
269. Tu P.H., Galvin J.E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J.Q., Lee V.M. Glial cytoplasmatic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 1998, 44:415-422.
270. Uematsu D., Hamada J., Gotoh F. Brainstem auditory evoked responses and CT findings in multiple system atrophy. J Neurol Sci 1987, 77:161-171.
271. Umapathi T., Chaudhry V., Comblath D., Drachman D., Griffin J., Kuncl R. Head drop and camptocormia. J Neurol Neurosurg Psychiatry 2002, 73:1-7.
272. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neuronal cell types. J Neurosci 1993, 13:981-989.
273. Valldeoriola F., Valls-Sole J., Tolosa E.S., Marti M.J. Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov Disord 1995, 10(5):550-555.
274. Vanacore N., Bonifati V., Fabbrini G., Colosimo C., Marconi R., Nicholl D., et al. Smoking habits in multiple system atrophy and progressive supranuclear palsy. Neurology 2000, 54:114-119.
275. van der Eecken H., Adams R.D., van Bogaert L. Striopallidalnigral degeneration. A hitherto undescribed lesion in paralysis agitans. J Neuropathol Exp Neurol 1960, 19:159-161.
276. van Royen E., Verhoeff N.F., Speelman J.D., Wolters E.C., Kuiper M.A., Janssen A.G. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 1231-IBZM single photon emission computed tomography. Arch Neurol 1993, 50:513-516.
277. Vodusek B. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord 2001, 16:600-607.
278. Vogels O.J., Vellman J., Oyen W.J., Horstink M.W. Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration. J Neurol Sci 2000, 180:62-65.
279. Wakabayashi K., Hayashi S., Kakita A., Yamada M., Toyoshima Y., Yoshimoto M., Takahashi H. Accumulation of alpha-synucle in/NACP is acytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 1998, 96(5):445-452.
280. Wakabayashi K., Ikeuchi T., Ishikawa A., Takahashi H. Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter. J Neurol Sci 1998, 156:114-117.
281. Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H. Alpha-synclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998, 249:180-182.
282. Wakai M., Kume A., Takahashi A., Ando T., Hashizume Y. A study of parkinsonism in multiple system atrophy: clinical and MRI correlation. Acta Neurologica Scandinavica 1994, 90:225-231.
283. Waldner R., Puschban Z., Scherfler C., Seppi K., Jellinger K., Poewe W. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). Neuroscience 2001, 102:581-592.
284. Watanabe H., Saito Y., Terao S., Ando T., Kachi T., Mukai E., et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002, 125:1070-1083.
285. Wenning G.K., Wagner S., Daniel S.E., Quinn N.P. Multiple system atrophy: sporadic or familial?. Lancet 1993, 342:681.
286. Wenning G.K., Ben-Shlomo Y., Magalhaes M., Daniel S.E., Quinn N.P. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994, 117:835-845.
287. Wenning G.K., Jäger R., Kendall B., et al. Is cranial computerized tomography (CT) useful in the diagnosis of multiple system atrophy?. Mov Disord 1994, 9:333-336.
288. Wenning G.K., Quinn N., Magalhaes M., Mathias C., Daniel S.E. Minimal change "multiple system atrophy. Mov Disord 1994, 9:161-166.
289. Wenning G.K., Quinn N. Are Lewy bodies non-specific epiphenomena of nigral damage. Mov Disord 1994, 9:378-379.
290. Wenning G.K., Ben-Shlomo Y., Magalhaes M., Daniel S.E., Quinn N.P. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995, 58:160-166.
291. Wenning G.K., Granata R., Laboyrie P.M., quinn N.P., Jenner P., Marsden C.D. Reversal of behavioral abnormalities by fetal allografts in a novel rat model of striatonigral de generation. Mov Disord 1996, 11:522-532.
292. Wenning G.K., Tison F., Elliott L., Quinn N.P., Daniel S.E. Olivopontocerebellar pathology in multiple system atrophy. Mov Disord 1996, 11:157-162.
293. Wenning G.K., Kraft E., Beck R., Fowler C.J., Mathias C.J., Quinn N.P., Harding A.E. Cerebellar presentation of multiple system atrophy. Mov Disord 1997, 12:115-117.
294. Wenning G.K., Tison F., Ben-Shlomo Y., Daniel S.E., Quinn N.P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997, 12:133-147.
295. Wenning G.K., Quinn N.P. Multiple system atrophy. Bailliere's Clin Neurol 1997, 6:187-204. N.P. Quinn, Parkinsonism (Eds.).
296. Wenning G.K., Smith S.J.M. Magnetic brain stimulation in multiple system atrophy. Mov Disord 1997, 12:452-453.
297. Wenning G.K., Ebersbach G., Verny M., Chaudhuri K.R., Jellinger K., McKee A., et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999, 14:947-950.
298. Wenning G.K., Granata R., Puschban Z., Scherfler C., Poewe W. Neural transplantation in animal models of multiple system atrophy: a review. J Neural Transm 1999, 55:103-113.
299. Wenning G.K., Scherfler C., Granata R., Bösch S., Verny M., Chaudhuri K.R. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmorten confirmed parkinsonian syndromes: a clinic opathological study. J Neurol Neurosurg Psychiatry 1999, 67:620-623.
300. Wenning G.K., Ben-Shlomo Y., Hughes A., Daniel S.E., Lees A.J., Quinn N.P. What clinical features are most useful to distin guish definite multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 2000, 68:434-440.
301. Wenning G.K., Jellinger K.J., Quinn N.P., Poewe W.H. An early report of striatonigral degeneration. Mov Disord 2000, 15:159-162.
302. Wenning G.K., Seppi K., Sampaio C., Quinn N.P., Poewe W., Tison F. European Multiple System Atrophy Study Group (EMSA-SG): Validation of the Unified MSA Rating Scale (UMSARS). Mov Disord 2002, 17(suppl 5):252.
303. Wenning G.K., Colosimo C., Geser F., Poewe W. Multiple system atrophy. Lancet Neurol 2004, 3:93-103.
304. Wenning G.K., Geser F. Diagnosis and treatment of multiple system atrophy: an update. Advances in Clinical Neuroscience & Rehabilitation 2004, 3:5-10.
305. Wermuth L., Joensen P., Bunger N., Jeune B. High prevalence of Parkinson's disease in the Faroe Islands. Neurology 1997, 49:426-432.
306. Wessel K., Huss G.P., Brückmann H., Kömpf D. Follow-up of neurophysiological tests and CT in late-onset cerebellar ataxia and multiple system atrophy. J Neurol 1993, 240:168-176.
307. Williams A., Hanson D., Calne D.B. Vocal cord paralysis in the Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 1979, 42:151-153.
308. Winkler A.S., Marsden J., Parton M., Watkins P.J., Chaudhuri K.R. Erythropoietin deficiency and anaemia in multiple system atrophy. Mov Disord 2001, 16:233-239.
309. Wright R.A., Kaufmann H.C., Perera R., Opfer-Gehrking T.L., McElligott M.A., Sheng K.N. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998, 51:120-124.
310. Wu Y.R., Chen C.M., Ro L.S., Chen S.T., Tang L.M. Vocal cord paralysis as an initial sign of multiple system atrophy in the central nervous system. J Formos Med Assoc 1996, 95:804-806.
311. Wüllner U., Klockgether T., Petersen D., Naegele T., Dichgans J. Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology 1993, 43:318-325.
312. Yamada T., McGeer P.L. Oligodendroglial microtubular masses: an abnormality observed in some human neurodegenerative diseases. Neurosci Lett 1990, 120:163-166.
313. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 1998, 155:60-67.
314. Zesiewicz T.A., Helal M., Hauser R.A. RA Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord 2000, 15:305-308.
315. Ziegler M.G., Lake C.R., Kopin I.J. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 1977, 296:293-297.